Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-2.69%
1,068.24
-29.57
-2.69%
—1,097.811,087.761,087.761,067.42——
SIXC
Communications
SIXC
Communications
SIXC
-0.89%
606.59
-5.44
-0.89%
—612.03612.03612.03606.13——
SIXE
Energy
SIXE
Energy
SIXE
+2.19%
1,247.21
+26.78
+2.19%
—1,220.431,221.991,247.601,221.99——
SIXI
Industrials
SIXI
Industrials
SIXI
-1.82%
1,727.58
-31.94
-1.82%
—1,759.521,754.311,754.311,723.60——
SIXM
Financials
SIXM
Financials
SIXM
-0.32%
629.54
-2.00
-0.32%
—631.54631.27633.99628.63——
SIXR
Staples
SIXR
Staples
SIXR
-0.42%
853.60
-3.56
-0.42%
—857.16858.91861.71852.33——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-1.56%
212.04
-3.37
-1.56%
—215.41215.41215.41211.88——
SIXT
Technology
SIXT
Technology
SIXT
-1.78%
3,549.76
-64.39
-1.78%
—3,614.153,556.243,598.363,516.86——
SIXU
Utilities
SIXU
Utilities
SIXU
-2.40%
886.49
-21.81
-2.40%
—908.30906.55906.55885.88——
SIXV
Health care
SIXV
Health care
SIXV
-1.08%
1,464.34
-16.06
-1.08%
—1,480.401,479.551,484.431,462.52——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-1.84%
2,354.25
-44.12
-1.84%
—2,398.372,373.092,373.092,350.27——
PHIO:NASDAQ
Phio Pharmaceuticals Corp
$1.07
-4.46%
(-0.050) 1D
May 15, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PHIO...
Open
$1.10
High
$1.12
Low
$1.05
Mkt. cap
12.43M
Avg. vol.
142.04K
Volume
228.66K
52-wk high
$4.19
52-wk low
$0.81
EPS
-$1.49
Beta
0.84
Shares outstanding
11.62M
No. of employees
6
News stories
From sources across the web
Profile
Phio Pharmaceuticals Corporation is a US clinical stage biotechnology company developing its INTASYL siRNA in immuno-oncology. Formerly known as RXi Pharmaceuticals, the company's name was changed to Phio Pharmaceuticals in 2018. Wikipedia
About Phio Pharmaceuticals Corp
CEO-
Employees6
Founded2011
Headquarters-
SectorBiotechnology
Websitephiopharma.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
1.07M
1.18M
1.48M
-
Cost of revenue
1.07M
1.18M
1.48M
-
Research and development expenses
-
-
-
2.79M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.24M
1.32M
1.06M
1.37M
Operating expense
1.24M
1.32M
1.06M
4.17M
Total operating expenses
2.31M
2.50M
2.53M
4.17M
Operating income
-2.31M
-2.50M
-2.53M
-4.17M
Other non operating income
143.00K
-
-
3.00K
EBT including unusual items
-2.17M
-2.39M
-2.37M
-4.00M
EBT excluding unusual items
-2.17M
-2.39M
-2.37M
-4.00M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.17M
-2.39M
-2.37M
-4.00M
Net profit margin
-
-
-
-
Earnings per share
-
-0.44
-0.15
-0.34
Interest and investment income
-
113.00K
163.00K
161.00K
Interest expense
-
-
-
-
Net interest expenses
-
113.00K
163.00K
161.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.31M
-2.50M
-2.53M
-4.17M
Gain or loss from assets sale
-
-
-
-3.00K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer